OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potential molecular mechanisms and clinical progress in liver metastasis of breast cancer
Hanyuan Liu, Xiao Li, Haiyang Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112824-112824
Open Access | Times Cited: 13
Hanyuan Liu, Xiao Li, Haiyang Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112824-112824
Open Access | Times Cited: 13
Showing 13 citing articles:
Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer
Yu Wang, Qianmei Wang, Xiaowen Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Yu Wang, Qianmei Wang, Xiaowen Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Balancing act: The dual role of claudin‐2 in disease
Shanshan Wu, Jia Gao, Yiran Han, et al.
Annals of the New York Academy of Sciences (2025)
Closed Access
Shanshan Wu, Jia Gao, Yiran Han, et al.
Annals of the New York Academy of Sciences (2025)
Closed Access
Predictive value of ultrasound assessment of axillary and brachial artery parameters for lymph node metastasis in breast cancer patients
Jingcheng Bi, Tianqi Yao, Yu Yao, et al.
American Journal of Cancer Research (2025) Vol. 15, Iss. 3, pp. 1066-1080
Closed Access
Jingcheng Bi, Tianqi Yao, Yu Yao, et al.
American Journal of Cancer Research (2025) Vol. 15, Iss. 3, pp. 1066-1080
Closed Access
Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer
Yongxia Li, Yong Li, Taolang Li, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Yongxia Li, Yong Li, Taolang Li, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Breast cancer liver metastasis: Pathogenesis and clinical implications
Cuiwei Liu, Srivarshini Cherukupalli Mohan, Jielin Wei, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Cuiwei Liu, Srivarshini Cherukupalli Mohan, Jielin Wei, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Circular RNA and its potential diagnostic and therapeutic values in breast cancer
Di Gao, Can Cui, Yaoxuan Jiao, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Di Gao, Can Cui, Yaoxuan Jiao, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway
Hongkun Li, Jiawei Li, Yifan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Hongkun Li, Jiawei Li, Yifan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study
Li Chen, Qiang Liu, Chunlei Tan, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 75-94
Open Access | Times Cited: 2
Li Chen, Qiang Liu, Chunlei Tan, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 75-94
Open Access | Times Cited: 2
The pathogenesis of liver cancer and the therapeutic potential of bioactive substances
Song Gao, Xingyue Jiang, Liang Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Song Gao, Xingyue Jiang, Liang Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Euphorbia factor L1 suppresses breast cancer liver metastasis via DDR1-mediated immune infiltration
Dongjing Jiang, XiaoQin Gao, Rulan Tan, et al.
Aging (2023) Vol. 15, Iss. 17, pp. 9217-9229
Open Access | Times Cited: 4
Dongjing Jiang, XiaoQin Gao, Rulan Tan, et al.
Aging (2023) Vol. 15, Iss. 17, pp. 9217-9229
Open Access | Times Cited: 4
Deciphering the Role of MicroRNAs in the Development of Organotropic Metastasis in Triple-negative Breast Cancer
Deepshikha Rathore, Sweny Jain, Nandani Dharwal, et al.
Aspects of Molecular Medicine (2024), pp. 100057-100057
Open Access
Deepshikha Rathore, Sweny Jain, Nandani Dharwal, et al.
Aspects of Molecular Medicine (2024), pp. 100057-100057
Open Access
Signals of adverse drug events of Tamoxifen: An analysis of FDA Adverse Event Reporting System data from 2015 to 2020
Jianru Wu, Biyu Tang, Xiao Xiao, et al.
Authorea (Authorea) (2023)
Open Access
Jianru Wu, Biyu Tang, Xiao Xiao, et al.
Authorea (Authorea) (2023)
Open Access
Breast cancer progression to other organs
Nirali Budhbhatti, Ramswaroop Saini
International Journal of Health Sciences (2022), pp. 13945-13958
Open Access
Nirali Budhbhatti, Ramswaroop Saini
International Journal of Health Sciences (2022), pp. 13945-13958
Open Access
